Nicholas J. Gonzalez, M.D.Posted 2 years ago under Uncategorized
- Dear Patients, Family, Friends, and Colleagues:
- It is with great sadness that the office of Nicholas J. Gonzalez, M.D. relays news of his untimely death on Tuesday, July 21, 2015. The cause of death was cardiac related, it appears, as he suddenly collapsed and was unable to be revived. Dr. Gonzalez was in excellent health otherwise so his passing is quite unexpected.
- Currently, his family is taking care of funeral arrangements and Dr. Linda Isaacs and his office staff are tending to patients. In the interim, please know Dr. Gonzalez’ office will keep you posted on plans by way of this announcement list. Moving forward, his team will do their best to navigate tasks and transitions seamlessly and we thank you in advance for your kind consideration. If you are a patient and have an upcoming appointment, please call the office to let us know if you wish to reschedule with Dr. Isaacs.
- Dr. Gonzalez leaves his beloved wife, Mary Beth, a legacy of Christian faith, healing, and genuine love for people and the pursuit of medicine.
- This is a deeply distressing time for all of us. We appreciate your thoughts and prayers.
Nicholas J. Gonzalez, M.D., graduated from Brown University, Phi Beta Kappa, magna cum laude, with a degree in English Literature. He subsequently worked as a journalist, first at Time Inc., before pursuing premedical studies at Columbia. He then received his medical degree from Cornell University Medical College in 1983. During a postgraduate immunology fellowship under Dr. Robert A. Good, considered the father of modern immunology, he completed a research study evaluating an aggressive nutritional therapy in the treatment of advanced cancer. Since 1987, Dr. Gonzalez was in private practice in New York City, treating patients diagnosed with cancer and other serious degenerative illnesses. His nutritional research has received substantial financial support from Procter & Gamble and Nestle. Results from a pilot study published in 1999 described the most positive data in the medical literature for pancreatic cancer.
The official announcement on his website July 22, 2012: